Low-dose T3 improves the bed rest model of simulated weightlessness in men and women

Jennifer C. Lovejoy, Steven R. Smith, Jeffrey J. Zachwieja, George A. Bray, Marlene M. Windhauser, Peter J. Wickersham, Johannes D Veldhuis, Richard Tulley, Jacques A. De La Bretonne

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

This study tested the hypothesis that low-dose 3,5,3'-triiodothyronine (T3) administration during prolonged bed rest improves the ground-based model of spaceflight. Nine men (36.4 ± 1.3 yr) and five women (34.2 ± 2.1 yr) were studied. After a 5-day inpatient baseline period, subjects were placed at total bed rest with 6°head-down tilt for 28 days followed by 5- day recovery. Fifty micrograms per day of T3 (n = 8) or placebo (n = 6) were given during bed rest. Serum T3 concentrations increased twofold, whereas thyroid-stimulating hormone was suppressed in treated subjects. T3-treated subjects showed significantly greater negative nitrogen balance and lost more weight (P = 0.02) and lean mass (P < 0.0001) than placebo subjects. Protein breakdown (whole body [13C]leucine kinetics) increased 31% in the T3 group but only 8% in the placebo group. T3-treated women experienced greater changes in leucine turnover than men, despite equivalent weight loss. Insulin sensitivity fell by 50% during bed rest in all subjects (P = 0.005), but growth hormone release and insulin release were largely unaffected. In conclusion, addition of low-dose T3 to the bed rest model of muscle unloading improves the ground-based simulation of spaceflight and unmasks several important gender differences.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Volume277
Issue number2 40-2
StatePublished - Aug 1999
Externally publishedYes

Fingerprint

Weightlessness Simulation
Weightlessness
Bed Rest
Leucine
Insulin
Triiodothyronine
Thyrotropin
Space Flight
Unloading
Growth Hormone
Placebos
Muscle
Nitrogen
Recovery
Kinetics
Proteins
Insulin Resistance
Weight Loss
Inpatients
Weights and Measures

Keywords

  • Gender differences
  • Growth hormone
  • Insulin resistance
  • Spaceflight
  • Thyroid hormones

ASJC Scopus subject areas

  • Physiology
  • Endocrinology
  • Biochemistry
  • Physiology (medical)

Cite this

Lovejoy, J. C., Smith, S. R., Zachwieja, J. J., Bray, G. A., Windhauser, M. M., Wickersham, P. J., ... De La Bretonne, J. A. (1999). Low-dose T3 improves the bed rest model of simulated weightlessness in men and women. American Journal of Physiology - Endocrinology and Metabolism, 277(2 40-2).

Low-dose T3 improves the bed rest model of simulated weightlessness in men and women. / Lovejoy, Jennifer C.; Smith, Steven R.; Zachwieja, Jeffrey J.; Bray, George A.; Windhauser, Marlene M.; Wickersham, Peter J.; Veldhuis, Johannes D; Tulley, Richard; De La Bretonne, Jacques A.

In: American Journal of Physiology - Endocrinology and Metabolism, Vol. 277, No. 2 40-2, 08.1999.

Research output: Contribution to journalArticle

Lovejoy, JC, Smith, SR, Zachwieja, JJ, Bray, GA, Windhauser, MM, Wickersham, PJ, Veldhuis, JD, Tulley, R & De La Bretonne, JA 1999, 'Low-dose T3 improves the bed rest model of simulated weightlessness in men and women', American Journal of Physiology - Endocrinology and Metabolism, vol. 277, no. 2 40-2.
Lovejoy JC, Smith SR, Zachwieja JJ, Bray GA, Windhauser MM, Wickersham PJ et al. Low-dose T3 improves the bed rest model of simulated weightlessness in men and women. American Journal of Physiology - Endocrinology and Metabolism. 1999 Aug;277(2 40-2).
Lovejoy, Jennifer C. ; Smith, Steven R. ; Zachwieja, Jeffrey J. ; Bray, George A. ; Windhauser, Marlene M. ; Wickersham, Peter J. ; Veldhuis, Johannes D ; Tulley, Richard ; De La Bretonne, Jacques A. / Low-dose T3 improves the bed rest model of simulated weightlessness in men and women. In: American Journal of Physiology - Endocrinology and Metabolism. 1999 ; Vol. 277, No. 2 40-2.
@article{b2732d958ba541349259e12d96efcd7a,
title = "Low-dose T3 improves the bed rest model of simulated weightlessness in men and women",
abstract = "This study tested the hypothesis that low-dose 3,5,3'-triiodothyronine (T3) administration during prolonged bed rest improves the ground-based model of spaceflight. Nine men (36.4 ± 1.3 yr) and five women (34.2 ± 2.1 yr) were studied. After a 5-day inpatient baseline period, subjects were placed at total bed rest with 6°head-down tilt for 28 days followed by 5- day recovery. Fifty micrograms per day of T3 (n = 8) or placebo (n = 6) were given during bed rest. Serum T3 concentrations increased twofold, whereas thyroid-stimulating hormone was suppressed in treated subjects. T3-treated subjects showed significantly greater negative nitrogen balance and lost more weight (P = 0.02) and lean mass (P < 0.0001) than placebo subjects. Protein breakdown (whole body [13C]leucine kinetics) increased 31{\%} in the T3 group but only 8{\%} in the placebo group. T3-treated women experienced greater changes in leucine turnover than men, despite equivalent weight loss. Insulin sensitivity fell by 50{\%} during bed rest in all subjects (P = 0.005), but growth hormone release and insulin release were largely unaffected. In conclusion, addition of low-dose T3 to the bed rest model of muscle unloading improves the ground-based simulation of spaceflight and unmasks several important gender differences.",
keywords = "Gender differences, Growth hormone, Insulin resistance, Spaceflight, Thyroid hormones",
author = "Lovejoy, {Jennifer C.} and Smith, {Steven R.} and Zachwieja, {Jeffrey J.} and Bray, {George A.} and Windhauser, {Marlene M.} and Wickersham, {Peter J.} and Veldhuis, {Johannes D} and Richard Tulley and {De La Bretonne}, {Jacques A.}",
year = "1999",
month = "8",
language = "English (US)",
volume = "277",
journal = "American Journal of Physiology - Renal Fluid and Electrolyte Physiology",
issn = "1931-857X",
publisher = "American Physiological Society",
number = "2 40-2",

}

TY - JOUR

T1 - Low-dose T3 improves the bed rest model of simulated weightlessness in men and women

AU - Lovejoy, Jennifer C.

AU - Smith, Steven R.

AU - Zachwieja, Jeffrey J.

AU - Bray, George A.

AU - Windhauser, Marlene M.

AU - Wickersham, Peter J.

AU - Veldhuis, Johannes D

AU - Tulley, Richard

AU - De La Bretonne, Jacques A.

PY - 1999/8

Y1 - 1999/8

N2 - This study tested the hypothesis that low-dose 3,5,3'-triiodothyronine (T3) administration during prolonged bed rest improves the ground-based model of spaceflight. Nine men (36.4 ± 1.3 yr) and five women (34.2 ± 2.1 yr) were studied. After a 5-day inpatient baseline period, subjects were placed at total bed rest with 6°head-down tilt for 28 days followed by 5- day recovery. Fifty micrograms per day of T3 (n = 8) or placebo (n = 6) were given during bed rest. Serum T3 concentrations increased twofold, whereas thyroid-stimulating hormone was suppressed in treated subjects. T3-treated subjects showed significantly greater negative nitrogen balance and lost more weight (P = 0.02) and lean mass (P < 0.0001) than placebo subjects. Protein breakdown (whole body [13C]leucine kinetics) increased 31% in the T3 group but only 8% in the placebo group. T3-treated women experienced greater changes in leucine turnover than men, despite equivalent weight loss. Insulin sensitivity fell by 50% during bed rest in all subjects (P = 0.005), but growth hormone release and insulin release were largely unaffected. In conclusion, addition of low-dose T3 to the bed rest model of muscle unloading improves the ground-based simulation of spaceflight and unmasks several important gender differences.

AB - This study tested the hypothesis that low-dose 3,5,3'-triiodothyronine (T3) administration during prolonged bed rest improves the ground-based model of spaceflight. Nine men (36.4 ± 1.3 yr) and five women (34.2 ± 2.1 yr) were studied. After a 5-day inpatient baseline period, subjects were placed at total bed rest with 6°head-down tilt for 28 days followed by 5- day recovery. Fifty micrograms per day of T3 (n = 8) or placebo (n = 6) were given during bed rest. Serum T3 concentrations increased twofold, whereas thyroid-stimulating hormone was suppressed in treated subjects. T3-treated subjects showed significantly greater negative nitrogen balance and lost more weight (P = 0.02) and lean mass (P < 0.0001) than placebo subjects. Protein breakdown (whole body [13C]leucine kinetics) increased 31% in the T3 group but only 8% in the placebo group. T3-treated women experienced greater changes in leucine turnover than men, despite equivalent weight loss. Insulin sensitivity fell by 50% during bed rest in all subjects (P = 0.005), but growth hormone release and insulin release were largely unaffected. In conclusion, addition of low-dose T3 to the bed rest model of muscle unloading improves the ground-based simulation of spaceflight and unmasks several important gender differences.

KW - Gender differences

KW - Growth hormone

KW - Insulin resistance

KW - Spaceflight

KW - Thyroid hormones

UR - http://www.scopus.com/inward/record.url?scp=0032827098&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032827098&partnerID=8YFLogxK

M3 - Article

C2 - 10444434

AN - SCOPUS:0032827098

VL - 277

JO - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

JF - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

SN - 1931-857X

IS - 2 40-2

ER -